EdgarLookup
SC 13G/A

AMENDMENT NO 1 TO SCHEDULE 13G

Company
CytomX Therapeutics, Inc.
Filed
February 14, 2018
Accession Number
0001193125-18-045175
View Document ↗ View on SEC.gov ↗